Campion Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$573K Sell
4,761
-39
-0.8% -$4.5K 0.39% 39
2025
Q4
$505K Sell
4,800
-12
-0.2% -$1.13K 0.35% 47
2025
Q3
$404K Sell
4,812
-695
-13% -$57.2K 0.29% 57
2025
Q2
$436K Sell
5,507
-135
-2% -$10.7K 0.33% 54
2025
Q1
$506K Hold
5,642
0.39% 48
2024
Q4
$561K Sell
5,642
-37
-0.7% -$3.81K 0.42% 40
2024
Q3
$645K Sell
5,679
-85
-1% -$10.1K 0.47% 37
2024
Q2
$714K Hold
5,764
0.56% 33
2024
Q1
$761K Buy
5,764
+62
+1% +$7.64K 0.59% 30
2023
Q4
$622K Sell
5,702
-60
-1% -$6.23K 0.53% 39
2023
Q3
$593K Hold
5,762
0.55% 37
2023
Q2
$665K Buy
5,762
+300
+5% +$34.1K 0.59% 34
2023
Q1
$581K Hold
5,462
0.55% 39
2022
Q4
$606K Hold
5,462
0.6% 36
2022
Q3
$470K Hold
5,462
0.5% 45
2022
Q2
$498K Hold
5,462
0.49% 45
2022
Q1
$448K Buy
5,462
+330
+6% +$26K 0.38% 57
2021
Q4
$393K Hold
5,132
0.33% 62
2021
Q3
$385K Hold
5,132
0.34% 63
2021
Q2
$399K Sell
5,132
-770
-13% -$57.3K 0.33% 59
2021
Q1
$434K Buy
+5,902
New +$435K 0.33% 59

Other funds holding MRK

Campion Asset Management's MRK Position: Q1 2026 in Review

Campion Asset Management reduced its Merck (MRK) stake by 0.81% in Q1 2026, selling an estimated $4.5K and leaving 4,761 shares worth $573K. The position accounts for 0.39% of the portfolio, ranked #39.

Campion Asset Management first reported a position in MRK in Q1 2021 and has held it in 21 quarters since. The position peaked at $761K in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Campion Asset Management held 4,761 shares of Merck worth $573K as of Q1 2026.
  • Campion Asset Management sold 39 Merck shares in Q1 2026, an estimated $4.5K.
  • Merck made up 0.39% of Campion Asset Management's portfolio in Q1 2026, its #39 holding.
  • Campion Asset Management first reported a position in Merck in Q1 2021 and has held it in 21 quarters since.
  • Campion Asset Management's Merck position peaked at $761K in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Campion Asset Management's 13F filing for Q1 2026, filed 14 May 2026.